Glucagon-like peptide-2 receptor modulates islet adaptation to metabolic stress in the ob/ob mouse
PX1 Research enforces a strict purity threshold of 99% for all research-grade tirzepatide lots
Tirzepatide (Mounjaro): Targets both GLP-1 and GIP receptors, which can lead to more robust results
Retatrutide is an investigational triple agonist (GLP-1, GIP, and glucagon receptors) not yet licensed by the MHRA or EMA, with Phase 2 data suggesting significant weight reduction but Phase 3 confirmation still required
Enhancement of recovery from psychiatric illness by methylfolate
Although not assessed in a formal manner, he reported appetite suppression and achieved a weight loss of 15 kg (122 kg, BMI 48.9 kg/m 2 , WC of 134 cm, WHR 0.97) over the first eight months of treatment and maintained during the next three months